Get access

Patient-control association study of the Leucine-Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients

Authors

  • Soraya Bardien PhD,

    Corresponding author
    1. Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, South Africa
    • Correspondence to: Dr. Soraya Bardien, Division of Molecular Biology and Human Genetics, University of Stellenbosch, PO Box 19063, Tygerberg, 7505, Cape Town, South Africa; sbardien@sun.ac.za

    Search for more papers by this author
  • Janine Blanckenberg PhD,

    1. Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, South Africa
    Search for more papers by this author
  • Lize van der Merwe PhD,

    1. Biostatistics Unit, Medical Research Council, Cape Town, South Africa
    2. Department of Statistics, University of the Western Cape, Cape Town, South Africa
    Search for more papers by this author
  • Matthew J. Farrer PhD,

    1. Department of Medical Genetics, University of British Columbia, Vancouver, Canada
    Search for more papers by this author
  • Owen A. Ross PhD

    1. Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA
    Search for more papers by this author

  • Funding agencies: Michael J Fox Foundation; Mayo Clinic Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50NS072187); South African Medical Research Council.

  • Relevant conflicts of interest/financial disclosures: Nothing to report.

  • Full financial disclosures and author roles may be found in the online version of this article.

No abstract is available for this article.

Ancillary